...
首页> 外文期刊>American Journal of Surgical Pathology >Skin involvement of mantle cell lymphoma may mimic primary cutaneous diffuse large b-cell lymphoma, leg type
【24h】

Skin involvement of mantle cell lymphoma may mimic primary cutaneous diffuse large b-cell lymphoma, leg type

机译:皮肤细胞淋巴瘤的皮肤涉及可能模仿初级皮肤弥漫性大B细胞淋巴瘤,腿型

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Mantle cell lymphoma (MCL) is a B-cell neoplasm with a variable and generally aggressive clinical course. So far our knowledge of skin involvement of MCL is limited. To understand the clinical and histopathologic features of MCL with skin involvement, the files of the Lymph Node Registry Kiel were screened for MCL diagnosed in the skin. Over a period of 13 years, 1321 biopsy specimens were diagnosed as MCL; among them, 14 patients (1%) showed skin involvement. Of these, skin was the initial site of manifestation in 6/11 (55%) cases. One patient presented with a skin-limited lymphoma. Furthermore, 7/12 (58%) patients presented with lesions on the leg. The lymphomas were highly proliferative with blastoid cytology in 12/14 (86%) cases. Moreover, the immunophenotype with expression of BCL2 (100%), MUM-1/IRF4 (83%), and IgM (82%) and lack of CD10 (25%) and BCL6 (0%) closely resembled the features of primary cutaneous diffuse large B-cell lymphoma, leg type. Solely the expression of cyclin D1 (100%) and the presence of t(11;14) (100%) allowed a distinction from cases of primary cutaneous diffuse large B-cell lymphoma, leg type. Only 2 MCL cases with skin involvement presented with classical cytology. Interestingly, in these 2 cases skin involvement occurred simultaneously in a lesion of coexisting primary cutaneous marginal zone lymphoma. Our data suggest that clinical presentation on the leg and blastoid cytology along with high proliferation and expression of Bcl2, Mum-1/IRF4, and IgM are typical for MCL involving the skin. Lymphomas with these features might be erroneously diagnosed as diffuse large B-cell lymphoma, leg type, if cyclin D1 staining is not performed. ? Copyright ? 2015 Wolters Kluwer Health, Inc. All rights reserved.
机译:地幔细胞淋巴瘤(MCL)是一种具有可变且普遍侵略性的临床过程的细胞肿瘤。到目前为止,我们对MCL的皮肤纳入的了解是有限的。为了了解MCL的临床和组织病理学特征,皮肤受累,筛选淋巴结注册表Kiel的文件,用于诊断在皮肤中的MCL。在13岁的时间内,1321个活检标本被诊断为MCL;其中,14名患者(1%)显示皮肤受累。其中,皮肤是6/11(55%)病例的初始表现遗址。一名患者呈现皮肤有限的淋巴瘤。此外,7/12(58%)患者患有病灶的病变。淋巴瘤在12/14(86%)病例中具有高度增殖的斑点细胞学。此外,具有Bcl2(100%),妈妈-1 / IRF4(83%)和IgM(82%)和IgM(82%)和缺乏CD10(25%)和Bcl6(0%)的免疫蛋白型非常类似于初级皮肤的特征弥漫性大B细胞淋巴瘤,腿型。仅表达细胞周期蛋白D1(100%)和T(11; 14)(100%)的存在允许区分初级皮肤弥漫性大B细胞淋巴瘤,腿型。只有2个MCL病例,皮肤参与患有古典细胞学。有趣的是,在这2例中,皮肤参与同时发生在共存初级皮肤边缘区淋巴瘤的病变中。我们的数据表明,腿部和斑点细胞学的临床介绍以及Bcl2,Mum-1 / IrF4和IgM的高增殖和表达是涉及皮肤的MCL的典型。淋巴瘤具有这些特征的淋巴瘤可能被错误地被诊断为弥漫性大B细胞淋巴瘤,腿型,如果没有进行细胞周期蛋白D1染色。还版权? 2015 Wolters Kluwer Health,Inc。保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号